Management of nicotine dependence in respiratory disorders smokers at risk for cardiovascular co-morbidity

摘要

Tobacco consumption has been recognized to harm human health, with special consideration to respiratory and cardiovascular risks. Cardiovascular co-morbidity is often encountered at smokers diagnosed with chronic respiratory disorders and this is increasing considerably mortality risk. We have conducted a study to determine impact of cardiovascular risk on smoking cessation outcomes in chronic respiratory disorders (CRD) smokers. We found 49% CRD smokers at cardiovascular risk and we have studied smoking cessation oucomes in both CRD with and without cardiovascular risk. All study population received smoking cessation counseling +/- medication ( varenicline standard 12 weeks cure), upon request, based on smoking status evaluation and smoking cessation motivational interview. We have found higher compliance to pharmacological treatment of nicotine dependence in CRD smokers at cardiovascular risk, compared to CRD smokers alone and higher quit smoking succes rates in smokers with both co-morbidities. We concluded routinely screening cardiovascular risk is recommended in current respiratory diseases practice. Also, personalized medical and psychological approach in smokers with CRD and concomitant cardiovascular co-morbidity would increase long term smoking abstinence rates.